(Q84060246)
Statements
Phase I/II trial of a COX-2 inhibitor with limited field radiation for intermediate prognosis patients who have locally advanced non-small-cell lung cancer: radiation therapy oncology group 0213 (English)
Elizabeth Gore
Kyounghwa Bae
Corey Langer
Martine Extermann
Benjamin Movsas
Paul Okunieff
Gregory Videtic